- Company Directors - C
- Chambon Philippe
Insider Trading History of Chambon Philippe
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Chambon Philippe since 2005.
The trader's CIK number is 1192212.
At the time of the last reporting, Chambon Philippe was the Director of Irhythm Technologies, Inc.. (stock ticker symbol IRTC).
Also see all insider trading activities at Irhythm Technologies, Inc..
Note that in the past
CHAMBON PHILIPPE also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Epocrates Inc (EPOC) by Chambon Philippe
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2011 | EPOC | 0 | $0 | 571,442 | $9,143,072 | 0 | $0 |
Yearly summary of insider trading at Nxstage Medical, Inc. (NXTM) by Chambon Philippe
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2012 | NXTM | 0 | $0 | 96,874 | $1,860,296 | 2,442 | $29,792 |
2011 | NXTM | 0 | $0 | 167,669 | $3,084,749 | 14,000 | $151,620 |
2010 | NXTM | 0 | $0 | 1,723,497 | $29,544,443 | 12,000 | $151,080 |
2006 | NXTM | 350,000 | $3,062,500 | 0 | $0 | 0 | $0 |
2005 | NXTM | 187,035 | $1,870,350 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Irhythm Technologies, Inc. (IRTC) by Chambon Philippe
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | IRTC | 25,000 | $425,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Chambon Philippe:
1. Epocrates Inc (EPOC)
2. Nxstage Medical, Inc. (NXTM)
3. Irhythm Technologies, Inc. (IRTC)
Table 1. Insider trading of Epocrates Inc (EPOC) by Chambon Philippe
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2011-02-07 | EPOC | Sale | 571,442 | 16.00 | 9,143,072 |
Table 2. Insider trading of Nxstage Medical, Inc. (NXTM) by Chambon Philippe
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2012-05-29 | NXTM | Option Ex | 2,442 | 12.20 | 29,792 |
2012-03-16 | NXTM | Sale | 74,401 | 19.28 | 1,434,748 |
2012-03-05 | NXTM | Sale | 22,473 | 18.94 | 425,548 |
2011-09-14 | NXTM | Sale | 20,110 | 18.58 | 373,643 |
2011-09-08 | NXTM | Sale | 53,102 | 18.42 | 978,191 |
2011-08-31 | NXTM | Sale | 57,480 | 18.47 | 1,061,598 |
2011-09-01 | NXTM | Sale | 36,977 | 18.16 | 671,317 |
2011-05-26 | NXTM | Option Ex | 14,000 | 10.83 | 151,620 |
2010-12-08 | NXTM | Sale | 26,749 | 22.59 | 604,233 |
2010-12-09 | NXTM | Sale | 300 | 22.51 | 6,752 |
2010-12-07 | NXTM | Sale | 168,975 | 23.20 | 3,920,895 |
2010-09-14 | NXTM | Option Ex | 12,000 | 12.59 | 151,080 |
2010-08-16 | NXTM | Sale | 100,000 | 17.01 | 1,701,000 |
2010-08-11 | NXTM | Sale | 500,000 | 16.00 | 8,000,000 |
2010-08-06 | NXTM | Sale | 33,400 | 16.03 | 535,402 |
2010-08-09 | NXTM | Sale | 44,700 | 16.19 | 723,871 |
2010-08-05 | NXTM | Sale | 37,100 | 16.36 | 606,881 |
2010-08-04 | NXTM | Sale | 100,000 | 16.33 | 1,632,600 |
2010-08-03 | NXTM | Sale | 300,000 | 16.32 | 4,894,800 |
2010-07-30 | NXTM | Sale | 28,800 | 16.09 | 463,507 |
2010-07-27 | NXTM | Sale | 204,473 | 16.97 | 3,469,906 |
2010-07-28 | NXTM | Sale | 130,200 | 16.90 | 2,200,380 |
2010-07-29 | NXTM | Sale | 48,800 | 16.07 | 784,216 |
2006-06-09 | NXTM | Buy | 350,000 | 8.75 | 3,062,500 |
2005-10-27 | NXTM | Buy | 187,035 | 10.00 | 1,870,350 |
Table 3. Insider trading of Irhythm Technologies, Inc. (IRTC) by Chambon Philippe
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-10-25 | IRTC | Buy | 25,000 | 17.00 | 425,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Chambon Philippe
(Director of Irhythm Technologies, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.